Wealth Quarterback
ABBV icon

Wealth Quarterback’s AbbVie ABBV Stock Holding History

Wealth Quarterback’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$336K Buy
1,284
+23
+2% +$5.9K 0.1% 127
2026
Q2 		$317K Buy
1,261
+23
+2% +$4.95K 0.1% 129
2026
Q1 		$269K Sell
1,238
-25
-2% -$5.55K 0.11% 136
2025
Q4 		$289K Sell
1,263
-66
-5% -$15K 0.1% 128
2025
Q3 		$308K Buy
1,329
+7
+0.5% +$1.42K 0.12% 125
2025
Q2 		$245K Buy
1,322
+29
+2% +$5.39K 0.12% 123
2025
Q1 		$271K Sell
1,293
-229
-15% -$44.5K 0.15% 105
2024
Q4 		$270K Sell
1,522
-119
-7% -$21.9K 0.13% 98
2024
Q3 		$324K Sell
1,641
-401
-20% -$74.8K 0.17% 90
2024
Q2 		$350K Sell
2,042
-4,339
-68% -$719K 0.2% 81
2024
Q1 		$1.16M Sell
6,381
-1,899
-23% -$327K 0.65% 29
2023
Q4 		$1.28M Buy
8,280
+174
+2% +$25.4K 0.78% 21
2023
Q3 		$1.21M Sell
8,106
-502
-6% -$73.7K 1.05% 20
2023
Q2 		$1.16M Buy
8,608
+1,558
+22% +$228K 0.8% 22
2023
Q1 		$1.12M Sell
7,050
-170
-2% -$26K 0.95% 18
2022
Q4 		$1.17M Buy
7,220
+21
+0.3% +$3.22K 0.97% 20
2022
Q3 		$966K Buy
7,199
+2,851
+66% +$409K 1.03% 23
2022
Q2 		$666K Buy
+4,348
New +$664K 0.52% 42
2021
Q3 		$196K Sell
1,809
-327
-15% -$37.4K 0.13% 111
2021
Q2 		$241K Buy
+2,136
New +$241K 0.15% 102
2020
Q4 		$234K Sell
2,182
-504
-19% -$48.4K 0.19% 96
2020
Q3 		$264K Hold
2,686
– – 0.24% 91
2020
Q2 		$264K Buy
2,686
+245
+10% +$21.6K 0.24% 91
2020
Q1 		$186K Sell
2,441
-9,330
-79% -$795K 0.17% 110
2019
Q4 		$218K Buy
+11,771
New +$977K 0.19% 102

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Wealth Quarterback's ABBV Position: Q3 2026 in Review

Wealth Quarterback increased its AbbVie (ABBV) stake by 1.8% in Q3 2026, buying an estimated $5.9K and bringing the position to 1,284 shares worth $336K. The position accounts for 0.1% of the portfolio, ranked #127.

Wealth Quarterback first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.28M in Q4 2023. 1,490 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Wealth Quarterback held 1,284 shares of AbbVie worth $336K as of Q3 2026.
  • Wealth Quarterback bought 23 AbbVie shares in Q3 2026, an estimated $5.9K.
  • AbbVie made up 0.1% of Wealth Quarterback's portfolio in Q3 2026, its #127 holding.
  • Wealth Quarterback first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • Wealth Quarterback's AbbVie position peaked at $1.28M in Q4 2023.
  • 1,490 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Wealth Quarterback's 13F filing for Q3 2026, filed 20 Oct 2026.